Abstract-Reliable inference of transcription regulatory networks is a challenging task in computational biology. Network component analysis (NCA) has become a powerful scheme to uncover regulatory networks behind complex biological processes. However, the performance of NCA is impaired by the high rate of false connections in binding information. In this paper, we integrate stability analysis with NCA to form a novel scheme, namely stability-based NCA (sNCA), for regulatory network identification. The method mainly addresses the inconsistency between gene expression data and binding motif information. Small perturbations are introduced to prior regulatory network, and the distance among multiple estimated transcript factor (TF) activities is computed to reflect the stability for each TF's binding network. For target gene identification, multivariate regression and t-statistic are used to calculate the significance for each TF-gene connection. Simulation studies are conducted and the experimental results show that sNCA can achieve an improved and robust performance in TF identification as compared to NCA. The approach for target gene identification is also demonstrated to be suitable for identifying true connections between TFs and their target genes. Furthermore, we have successfully applied sNCA to breast cancer data to uncover the role of TFs in regulating endocrine resistance in breast cancer.
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INTRODUCTION
W ITH the advent of high-throughput microarray technology, gene expression data have been generated and accumulated rapidly for many diseases or biological systems under specific conditions. Transcription factors (TFs) are special proteins that control and affect the rate of downstream genes' mRNA expression. It is important to identify TFs associated with a specific disease, which may lead to new therapeutic targets for drug discovery. Previously, researchers have shown that coexpressed genes are likely to be coregulated by a common set of TFs [1] , [2] , [3] . Nevertheless, coexpressed gene modules only provide functional (or indirect) evidence of gene regulatory relationship. In recent years, large-scale, genome-wide location analysis has provided strong direct evidence, i.e., protein-DNA binding information, for gene regulation [4] . Although this physical binding information is very useful, a TF's binding to short and highly conserved DNA sequences in promoter regions of its target genes may not function or result in gene regulation under a specific condition. Considering the complementary nature of functional gene expression data and physical binding data, some module-based approaches [5] , [6] , [7] , by integrating both types of data, make the computational results more trustable than those based on single type of data. Recent biological studies [8] , [9] have also provided strong support for such integrated approaches to identify regulatory networks reliably.
By identifying the transcriptional programs underneath, these methods are aimed to explain how TFs can cause the observed change in expression of their target genes. However, it is practically yet biologically important to prioritize within each module, which TF is more dominant or which target genes are more relevant to biological conditions. Due to a relatively low-resolution picture portrayed by such module-based methods, it is hard to distinguish which pairs of TF-gene relationship are more essential in regulatory networks. The identification of condition-specific TFs and their associated genes is the central idea of many recently developed methods [10] , [11] , [12] .
Several methods have been proposed to directly infer the TF-gene relationship by using regression or constraint regression methods [10] , [11] , [12] , [13] . By incorporating protein-DNA interaction (PDI) information into a log-linear model, which represents the regulatory relationship between regulatory signals and gene expression data, network component analysis (NCA) [10] has mathematically derived identifiable conditions and been applied successfully for several real biological problems. Although NCA can achieve a reasonably good, least-squared estimation of the regulatory signals (transcription factor activity (TFA)), its computational complexity is quite high due to the iterative algorithm adopted. To overcome this problem, FastNCA was proposed in [11] to directly calculate an analytical solution to TFA estimation based on both expression data and network structure. Its computational cost is much reduced as compared to that of NCA with just a little lower accuracy in TFA estimation. Both NCA and FastNCA utilize ChIP-chip data to construct initial network connections, and they assume the network information is accurate as in the case of yeast studies. However, complete ChIP-chip data are likely not available for most TFs in human disease studies. If we want to apply NCA to gene expression data acquired from patient tumors, binding motif sequence information is what we can use to construct initial regulatory networks.
It is well known that the rate of false-positive connections is quite high in binding motif data [14] , [15] . For one thing, the physical interaction does not mean functioning under a specific condition; for another, the motif sequence existing in a target gene's promoter region does not ensure that the TF-gene binding really happens. Moreover, the length of a motif sequence is usually quite short, which makes it more likely that false-positive connections occur in motif bindingbased regulatory network. In this case, with the inaccurate network topology to start with, the accuracy of NCA or FastNCA would be largely compromised and the estimated TFA may not reflect the true activity. Another practical issue that needs to be addressed is that both NCA and FastNCA require the number of samples should be larger than the number of TFs [10] , [11] . In real applications, we often need to identify a subset of condition-specific TFs from a large number of interested candidates. But for gene expression data under a specific condition, we usually have a small number of samples or replicates acquired in profiling studies. To loosen this requirement or assumption, an improved version of NCA is proposed in [13] . It requires that the number of the samples should be larger than the maximum number of TFs that actually regulate each gene, not the total number of TFs anymore. However, in binding motif data, if we look at the distribution of the number of TFs regulating each gene, the number varies in a large range (e.g., from 10 to several dozen). We still need a relatively large number of samples to use this improved version of NCA, which does not fully solve the problem encountered in many real applications.
In this paper, a stability-based NCA (sNCA) approach is first proposed to tackle the problem of regulatory network identification when inaccurate initial network topology exists. Stability analysis [16] is often used to indicate the sensitivity of the output of a system to random perturbations of the input. A stable system has the following property [17] , [18] , that is, removing one element (or some elements) in its input does not change much of its output. In other words, the empirical error, if thought as a random variable, should have a small variance for a stable system. If we treat any TFA estimation approach (e.g., the FastNCA method in our case) as "a mapping system"; at each time when we "input" a network topology, a set of TFAs can be computed as its "output." By assuming the consistency between gene expression data and network topology generated from TF-gene binding information, after some small perturbations introduced to the input network, the shift of the output TFAs should be quite small. To test the stability of this "mapping" system, we need generate multiple rounds of perturbations for stability analysis. To lower the computational complexity, FastNCA is used in this paper in conjunction with stability analysis. However, considering the high false-positive connections in binding motif information, even if the variance of the output TFAs is small, it is possible that the mean vector of TFAs is biased. Therefore, we design a risk function to evaluate both variance and mean for the activity of each TF, hence to prioritize all candidate TFs. The lower the risk of a TF is, the better this TF's associated network is supported by gene expression data.
Second, to solve the small sample size (relative to the number of TFs) problem, a sampling scheme is developed with the help of sNCA to sample the large TF space. Within each round of sampling, a small and fixed number of TFs are randomly sampled from the candidate TFs for sNCA to analyze the data. The number of TFs tested by sNCA in each round should be kept smaller than the number of samples. Based on an average risk value, all candidate TFs are prioritized after multiple rounds of sampling. A final set of TFs that have relatively stable performance is then identified for further target gene identification. With the estimated mean TFA, the regulatory strength (RS) on target genes is calculated by using multivariate regression [19] . Then, both RS and regression error are considered in t-statistic [19] to calculate the significance for each TF-gene connection, with which a score is assigned to prioritize all the genes. Finally, the sNCA approach assigns a risk value for each TF and provides a rank list of its target genes.
In Section 2, the sNCA approach and sampling procedure are described in detail. The focus is mainly on how to deal with inaccurate network information and overcome the limited sample size problem. Then, in Section 3, we demonstrate by simulation studies that our proposed method outperforms a number of alternative approaches. Specifically, we evaluate the performance of sNCA by varying several important factors controlling the network property and expression data quality. In Section 4, we apply our proposed approach to breast cancer data for regulatory network identification. Consequently, we have identified a set of transcriptional regulators and their target genes potentially associated with endocrine resistance in breast cancer.
METHODS
The sNCA approach is aimed to prioritize active conditionspecific TFs and their target genes by integrating gene expression data and binding motif information. Fig. 1 illustrates a flowchart of the proposed sNCA approach. By adopting the idea of stability analysis, multiple perturbed networks are generated from TF-gene binding motif information and used as input for sNCA to work on. For each perturbed network, based on condition specific gene expression data, FastNCA is used to provide an estimation of TFAs (with a relatively low computational cost). After multiple times of TFA estimation for many slightly perturbed networks, a risk function is calculated for each TF based on distances between TFA vectors. According to the principle of stability analysis, the value of the risk function reflects the stability performance for each TF's associated regulatory network. Then, the mean vector of estimated TFAs for each stable TF is passed to the third component of the algorithm, i.e., "gene identification." Multivariate regression and t-statistic calculation will work closely to prioritize the target genes for each TF. Finally, condition-specific regulatory network is reconstructed by the identified stable TFs and their associated high-rank target genes.
Stability Analysis of Regulatory Network
Based on binding motif information, we encode regulatory relationship from L TFs to N target genes as a network connectivity pattern B 2 ð0; 1Þ NÂL , which is a binary matrix with element b n;l ¼ 1 indicating potential regulatory relationship from lth TF to nth gene; b n;l ¼ 1; b n;l ¼ 0 indicating otherwise.
Gene expression measurements can be represented by a product of the regulating TFAs with a combinatorial power law model [8] , which is also a log-linear approximation of nonlinear kinetic systems. Also, considering that microarray data are typically measured with respect to a reference level and commonly used in log-ratio form, gene expression data can be modeled as a log-linear function as follows:
where X NÂM is the gene expression data matrix with element X n;m ¼ log½E n ðmÞ=E n ð0Þ, n ¼ 1; . . . ; N, and m ¼ 1; . . . ; M. Here, E n ðmÞ represents the expression level for nth gene of the mth sample. À n;m is associating noise value. A NÂL is the regulatory matrix with element A n;l , representing the RS of lth TF on nth gene, l ¼ 1; . . . ; L. S LÂM is the relative log form TFA matrix with element S l;m ¼ log½T F A l ðmÞ=T F A l ð0Þ, where T F A l ðmÞ is the activity for lth TF. E n ð0Þ and T F A l ð0Þ are the base line expression level for the nth gene and lth TFA vector, respectively. To ensure that the solution to (1) is a unique one, the matrix A should be full-column rank and matrix S should be full-row rank. In other words, for lth TF, its nonzero connection in the network should be larger than L, and the sample number M should be larger than TF number. We aim to study the regulatory role of the lth TF through its TFA estimation S l (lth row of S). The rationale behind this is that the TFA estimation of a condition-specific TF should be more robust to a small amount of perturbation than any nonspecific TF that generally lacks of support in datanetwork consistency. In this case, the interactions between this TF and its target genes are well supported by the condition-specific gene expression data.
According to the stability definition [14] , a mapping system (from regulatory network to TFA in our case) is weakly consistent if for any given " c > 0, it has
where IðlÞ is the risk function for lth TF after P times of perturbations on the initial regulatory network, and I 0 is the risk caused by the instability of the real regulatory mechanism. With the bounded risk function IðlÞ, weak consistency and strong consistency are equivalent [15] . For strong consistency, above function equals to
sup IðlÞ ¼ 0 in probability; ð3Þ
where I 0 equals to 0 for an ideally stable system.
Risk Function Design
Assuming that the initial network generated from binding motif information is B 0 . Through P times of independent perturbations on B 0 , we obtain P networks, B p , p ¼ 1; . . . ; P . According to (3), P should be assigned a value as large as possible (theoretically, approaching infinity). In practice, however, we cannot make P too large because of its associated computational cost. From our experience, a proper choice of the value of P is in a range from 30 to 50, which is statistically large enough for both mean and variance estimations of TFA. It should also ensure that, within each round of perturbation, at least one connection for each TF is altered. But the perturbation extent or degree should be kept relatively small, not altering the network topology too much, usually 2 to 5 percent of connections in our experiments. Mathematically, we denote the perturbation function as follows:
The TFA vector S l ðpÞ of the lth TF for pth perturbed network B p can be estimated by FastNCA as follows:
where function F NCA ðX; B p Þ represents FastNCA decomposition with input gene expression data X and network B p . After P times of above estimation procedure, for lth TF, we generate a set of estimates of TF activity vector,Ŝ l ðpÞ, 1 p P . Here, we use the cosine metric dðv 1 À v 2 Þ to calculate the distance between each pair of TFA vectors. This metric provides bounded cost function within (0, 1)
In this study, gene expression data are collected under two different conditions. For a TF, if its TFA has small deviation from its true mean and the true mean has significant change under two conditions, this TF is a good candidate for us to investigate. In our experiments, we design a guide vector to help identify those TFs that have significant activity changes across two conditions. Due to the use of standardized gene expression data, we can simply use À1 or 1 to encode the guide vector S l for each condition. Therefore, S l is simply a labeled vector to help select the TFA pattern of interest. The sample mean " S l can be represented as
We design a risk function IðlÞ to represent the inconsistency between the network that we have and the true regulatory network as supported by gene expression data, which can be calculated as follows:
where we introduce varying from 0 to 1 to control the weight of each component. Actually, when j ¼ i, according to (6) , d½Ŝ l ðiÞ ÀŜ l ðjÞ ¼ 0, so it does not contribute to the loss function. We, therefore, can finalize the risk function as follows:
Considering that 0 dðv 1 À v 2 Þ 1, we have the following property for the risk function: 0 IðlÞ ð1 À Þ þ ¼ 1, i.e., the risk function is bounded within [0, 1]. The first component in IðlÞ represents the average distance among all the TFA vectors, which is equivalent to the standard deviation information and can be expressed as
The second component actually measures how much the sample mean " S l is biased from the guide vector S l (desired true mean), which can be expressed as
If d v is large, the subnetwork linked to this specific TF is not stable, hence we need to exclude this TF. However, among the retained TFs, some of them do not have any significant change across the two conditions, with large d m . Such TFs make little sense for us. Thus, we use the upper bound of IðlÞ to represent the risk caused by the instability for lth TF activity as
Based on the definition of stability in (3), the closer the IðlÞ is to 0, the more stable the lth TF's subnetwork is. Based on IðlÞ, we can prioritize all the TFs in the network.
Sampling Scheme for Limited Data Samples
The above process is still based on the assumption that the number of gene expression samples (M) is larger than the number of TFs (L). However, we often encounter the case where L is much larger than M. With the help of sNCA, we develop a sampling scheme to prioritize all candidate TFs. The lowest risk assumption is that in the TF space, the prior probability distribution is uniform so that each TF has equal probability to be sampled. During the ith round of sampling, we randomly sample a small number (L s ) of TFs, where L s should be kept smaller than M. The value of L s , however, is determined in a condition specific way. As a practical solution to this problem, we could examine the distribution of gene degree (number of regulators) of the overall network. If the distribution shows a high peak around the degree range smaller than M, the value of L s can be set as the degree value corresponding to the peak location. However, if the peak falls in the range larger than M, empirically we can choose L s as large as possible to test more TFs, at most M TFs.
Then, according to the initial network topology B 0 , we select current sub network B s , which is regulated by only L s TFs. After P times of perturbations and sNCA estimations, the risk function IðlÞ for lth TF is calculated. After multiple rounds of sampling, each TF's average risk value is calculated. According to this value, all the candidate TFs are prioritized and the high ranked ones are selected as stable TFs.
Target Gene Identification
Remember that in the initial network B 0 , there are a lot of false-positive connections. How to identify the true-positive connections is what we want to solve in this section. In general, the higher the RS A n;l is, the more likely that nth gene is regulated by lth TF. But different genes are not directly comparable due to their different base line expression levels (E n ð0Þ in (1)). For the nth gene, we first use the activities of its potential regulators (may be one or multiple), TFAs, to regress its expression profile X n , and then use t-statistic [19] to calculate the statistical significance (p-value) of A n;l . The lower the p-value of A n;l is, the more significant (stronger) the regulatory connection is.
We use principle component analysis (PCA) to identify the main TFA vectorS l for the lth TF by using the results of sNCA TFA estimates. The first principle component is a direction on which the projected data have the largest variance; but at the same time, it is the vector that makes the sum of the squared distances between itself and the multiple estimates of TFA smallest [20] . Considering that we have already standardized the expression data, we use the first principle component as the mean value estimatioñ S l for the lth TF. We repeat this PCA process for each TF and finally generate the TFA matrixS. Reconsidering (1), by using the multivariable regression method [19] , the associated RS matrixÃ is calculated as follows:
where error n is the mean square fitting error for the nth gene and t n;l follows student t distribution with a degree of M À 1. Then, the p-value for A n;l (pvalueðA n;l Þ) is calculated based on t n;l according to the student t distribution.
To better differentiate the true-positive binding from a false-positive binding, we transform p-value into a score, g, as follows:
where " ¼ 10 À8 ; note that it is used to avoid the infinity case when p-value is close to 0. According to the score g, we can evaluate the significance of a binding interaction in the network in order to select the targets genes linked to active TFs. Until this step, both TFs and target genes are identified and the regulatory network is finally reconstructed.
SIMULATION
We generate TF-gene binding networks under the control of multiple factors, i.e., regulator number L, target gene number N, and "gene degree" D. The "gene degree," i.e., the degree of each gene, refers to the number of its regulators, which reflects the density of a network; the other two factors determine the size of a network.
To test the performance of sNCA for TF identification, we select L T TFs as true regulators to generate gene expression data, where RS is randomly assigned according to a Gaussian distribution. The remaining L F ð¼ L À L T Þ TFs have no relationship with the gene expression data generated in the simulation, which serve as false-positive TFs. The sample size of the gene expression data is M, which may vary from a number much smaller than L (the total TF number) to a number larger than L. In our simulated network, we use different proportions of false positives (PFP) to control the false connections of true regulators' target genes.
To test the performance of target gene identification, in gene expression data, we select half of the total N genes as "background" genes and randomly perturb their expression data to make them unrelated to the network (thus, "background" genes are irrelevant to network structure). Considering the noise in gene expression data, we use signal-to-noise ratio (SNR) to control the level of noise added to the expression data.
Before we apply sNCA to our studies, it is necessary to investigate how the tradeoff parameter affects the performance of the proposed sNCA approach. In this experiment, we set the average "gene degree" D to 3-4 (at most 6), TF number L to 80, and target gene number N to 2,000. The SNR of gene expression data (with 50 samples) is 4 dB. The PFP for the simulated networks is 30 percent. The area-under-the-curve (AUC) is used to measure the performance of sNCA for TF identification as the value of varies from 0 to 1. The experimental results are shown in Fig. 2 . From the figure, we can see that does affect the performance of sNCA (AUC ¼ 0:896 À 0:95), but not significantly (as AUC is larger than 0.895 for all values of ). The peak of AUC curve falls in the range of value from 0.1 to 0.2, as shown in the figure. Thus, we set a typical value in a range from 0.1 to 0.2 for our experiments reported later.
Impact of Network False Connections
First of all, we compare the performance of our proposed sNCA approach for TF identification with those of the improved NCA [10] and conventional least square (LS) regression [12] . Both NCA and LS use gene expression data and original network binding information without any perturbations. Due to the inaccurate network information, the performance of NCA would be degraded. The LS method is used here as a conventional regression method to provide a baseline performance. Note that the purpose of this comparison study is to demonstrate that stability analysis contributes to the improved performance greatly when the number of false connections is large. Here, we use similar simulation parameters as mentioned before. But the PFP for the networks varies from 10 to 70 percent, which provides us a clear picture that how much the false connections in the regulatory network would impact the TF-gene identification. The receiver operating characteristic (ROC) curves and precision-recall (PR) curves are shown in Fig. 3 for the three methods as compared. Table 1 From Fig. 3a and Table 1 , we see that when PFP is at 30 percent, the AUC values for the proposed sNCA, improved NCA and LS regression are 0.962, 0.909, and 0.835, respectively; accordingly, the accuracy values for TF identification are 0.92, 0.86, and 0.78, respectively, for the three methods. The two NCA-based methods significantly outperform the LS regression method for TF identification. More importantly, our sNCA approach performs better than the improved NCA, with 6 percent improvement in terms of both AUC and accuracy. In Fig. 3b , the PR curves also show that sNCA consistently outperforms the other two methods (i.e., NCA and LS). In Figs. 3c and 3d , we show the performance comparison result when the PFP value reaches 70 percent (i.e., with a high level of false-positive connections in the network). The sNCA approach performs much better than the NCA method, with an AUC value of 0.87, almost a 10 percent improvement over the NCA method. Again, as shown in Fig. 3d , the PR performance of sNCA is much better than that of NCA at this high level of PFP. As shown in Table 1 , when PFP is set at 10 percent (a low level of false connections in the network), sNCA and NCA can estimate TFAs more accurately than LS regression; note that sNCA and NCA have similar AUC performances of 0.995 and 0.971, respectively. From this comparison study (Table 1) , we can also see that with the increase of PFP, the performance of sNCA degrades much slower than NCA and LS; the AUC value of sNCA is kept above 0.9 even when FPR is at a level of 50 percent. Therefore, sNCA is more robust than NCA and LS to deal with a high level of false-positive connections existed in initial networks. The robustness of sNCA makes it more applicable to many real biological studies (such as the breast cancer study in our experiments).
For the identification of target genes, we can use two criteria to prioritize the gene list: one is based on t-statistic of RS as shown in (15) (or equivalently, a score g in (16)); the other one is based on the regression error as defined in (14) . It is worth noting that since t-statistic utilizes both RS and regression error, we think such a criterion is more robust than the criterion based on regression error alone. We present the ROC performance curves with networks under different PFP settings for target gene identification, as shown in Fig. 4 using different criterion (i.e., t-statistic or  regression error) .
From Figs. 4a and 4b, we can clearly see that the t-statisticbased approach is better and more robust than the regression error-based method. The AUC value in Fig. 4a varies from 0.968 to 0.843 (0.926 and 0.868 for the two middle curves) when PFP increases from 10 to 70 percent; as shown in Fig. 4b , AUC drops fast from 0.870 to 0.533 due to an increased number of false-positive connections existed in the network. Therefore, the t-statistic-based approach is preferred in real applications to provide more confident results for target gene identification.
In the following sections, we will further evaluate the performance of our sNCA method by studying the impact of multiple factors in different networks; especially, we will study the following important factors: network topology, noise in gene expression data, and the number of samples, to understand their impact on sNCA's performance. From different settings of these factors, the overall performance of sNCA is tested with simulated networks and gene expression data.
Impact of Network Topology
In this section, we study the impact of network topology on the performance of sNCA. Here, we further investigate whether network topology, such as network density and network size, has any significant impact on the performance of sNCA. For four simulation cases, the parameters (e.g., regulator number L and target gene number N) are similar to those described in the previous section, but with different "gene degree" D (a direct measure for network density). We design four different cases with different degree distribution, where Case 1 represents a network of low density, and Cases 2, 3, and 4 represent networks with relatively high density. The mean values of "gene degree" are 3, 5, and 7, respectively, for Cases 2, 3, and 4 (higher than that of Case 1). The performance of TF-gene identification for these four cases is summarized in Table 2 .
As mentioned in both NCA and FastNCA approaches [10] , [11] , with the same network size, the more network complexity is, the lower the accuracy of TFA estimation is. In other words, the density characteristic of a network will impact the estimation accuracy of either NCA or FastNCA. This is mainly a result of the increased number of simultaneously parameters that need to be estimated by the algorithm (when network density increases). In our scheme, even though we use FastNCA as the core component for TFA estimation, the stability analysis approach improves the robustness of sNCA for TF identification. The identification of TFs is not totally based on one network (as what NCA or FastNCA does), but multiple slightly perturbed networks to reflect the stability performance for each TF. Hence, the TFA estimation error, caused by the increased number of parameters, would be lowered by the mean value for TFA estimation using the sNCA approach. Consequently, sNCA can achieve a better performance than NCA for TF identification.
When the degree value is low (as in Case 1), the network is quite sparse. For a sparse network, the false connections may impact target gene identification significantly, but considering the network size, each TF is still supported by many of its true target genes. As shown in Table 2 , both sNCA and NCA can estimate TFA accurately and achieve a reasonably good AUC value. When the "gene degree" or density increases (as in Cases 2, 3, and 4), the improvement by stability analysis is more significant than that in Case 1. For the initial networks constructed from motif binding information, the average degree is about 10 in our studies, resulting in many networks with high density. From Table 2 , we can see that sNCA can provide an AUC performance around 0.9 when the degree varies from 5 to 7. This certainly gives us a great confidence in applying our method to breast cancer studies.
In Table 2 , we also present the performance of target gene identification using sNCA for the four cases simulated. The performance shows a reverse pattern as compared to that for TF identification. For Case 1, the AUC value is quite low (which is 0.718), but much higher when the degree increases (which is 0.926 for Case 4). This is not strange if we look into the details. For each gene, both RS and regression error are calculated through a multivariate regression method. When the network is quite sparse, the redundancy is quite low; a "true" target gene's expression data cannot be fitted well even if there is one false connection. When the density of network (i.e., "gene degree") increases, the impact of one false connection for this "true" target gene is lowered by the rest of true connections. Hence, a small fitting error for a certain gene is more likely to correctly reflect that most of this gene's connections are true. That enlarges its value of t in (15) and further differentiates "true" target genes from "background" genes (i.e., false target genes).
Another important factor that controls the network size is the TF number. In our scheme, we first identify active TFs and then pinpoint their target genes, which have significantly strong RS with these active TFs. Therefore, it is necessary to test the performance of sNCA for TF identification with different TF numbers for a fixed number of gene expression data samples. We aim to demonstrate that the sNCA approach is not impacted too much by the varying number of TFs. If it does hold, when we apply sNCA in real applications, we do not need to care too much about the number of candidate TFs in consideration. For the simulation study, we set the sample number M to 50 and target gene number N to 2,000. The SNR of gene expression data is 4 dB and PFP of the network is 30 percent.
As shown in Table 3 , when the number of TFs varies from 40 to 120, the AUC value of sNCA for TF identification degrades from 0.988 to 0.917. The performance drop is very small (0.07) within such a large range of TF number variation. The performance of sNCA is also kept higher than 0.9, which is much better than NCA. An improvement of 0.09 over NCA is achieved when the TF number is quite large. The performance for sNCA and NCA is significantly different when the TF number reaches 100 or higher. The reason behind this is mainly due to the network size used for estimation. Even if the improved NCA can work under this condition, it still utilizes the entire network for one round of TFA estimation. The low redundancy (caused by the increased size of the network under investigation) degrades NCA's performance. But for sNCA, we utilize a sampling scheme, so within each round of network sampling, we just test a subnetwork with much smaller size than the total network. The performance of sNCA for each subnetwork is thus ensured. That is why sNCA can work much better than NCA when the number of interested TFs is significantly larger than the number of samples.
Based on the results in Tables 2 and 3 , we can see that the topology of regulatory network has significant impact on the performance of any method for network reconstruction. Compared to NCA, the sNCA approach achieves an improved accuracy in TF identification; sNCA can also provide robust results for regulatory network identification even when the density (or size) of a network changes greatly. 
Impact of Noise in Gene Expression Data
It is well known that gene expression data measured by DNA microarray is quite noisy. The quality of gene expression data is always an important concern for regulatory network identification. It will directly impact the performance of identification both TF and target genes. It can be assumed that in real applications, the level of gene expression should be larger than the level of random noise in gene expression data. However, it is quite difficult to estimate the noise level of real gene expression data (e.g., breast cancer data in our experiments). Therefore, it is necessary to check the performance of TF-gene identification with a large range of noise levels in the simulation study. In this study, we set the network parameters to the same as what we have described in Section 3.1, but make SNR of gene expression data varying from À2 to 4 dB.
The experimental results are summarized in Table 4 . From the table, we can see that SNR does impact sNCA's performance. For TF identification, the AUC value decreases from 0.962 at SNR ¼ 4 dB to 0.863 at SNR ¼ À2 dB. But when SNR is at 0 dB (which means the power of gene expression data is equal to that of the noise level), the AUC value is still quite high, 0.933. That can be mainly attributed to that our method is a TFA-based approach for TF identification. Even when the level of noise is high, the dynamic change of TFA is not totally corrupted by the noise. With the stability analysis, the risk function between estimated TFAs is enlarged, but true (or active) TFs still have relatively lower risk than false (or inactive) TFs. The rank of the TFs is not affected too much by the noise in gene expression data. The improved NCA approach, however, directly utilizes the initial network and gene expression data. In this case, the TFA estimation is affected more likely than sNCA. That is why the performance of NCA degrades faster than that of sNCA. Since the LS method is totally based on regression, the noise in gene expression data directly impacts its regression accuracy. The AUC performance of LS drops below 0.8 when SNR is at 2 dB, and it further goes down to 0.737 around 0 dB.
In Table 4 , we also list the AUC values for target gene identification based on t-statistic. As we know, the regression error would be enlarged by the increased noise level in gene expression data. But we combine the RS with regression error to form the value of t-statistic. Hence, it can provide us a better way to differentiate true target genes from "background" genes. The p-value for a true gene may increase, but it is relatively lower than that of a "background" gene. From the bottom row of Table 4 , we can see that the AUC performance is quite robust to the noise level in gene expression data. When SNR varies from 4 to À2 dB, the AUC value shows a minor decrease of 0.05, varying from 0.912 to 0.860. When we apply this scheme to real data, the top ranked genes would have a high probability to be truly regulated by the identified TFs.
Impact of Sample Number
Besides the problem of false-positive connections in a network, it is important to address how to identify a large number of interested TFs with limited number of gene expression samples. Through a sampling scheme, we apply our sNCA method to several cases with different sample numbers, examining the impact of sample number M on the performance of sNCA. To compare with the improved NCA method, we control the degree for each gene (i.e., "gene degree" D) under 6, on an average of 3 to 4, which is smaller than the minimum value of M, 10 in our experiments. Note that our sampling scheme does not necessarily need to meet this assumption. We just need to keep the number of TFs sampled during each round no larger than M, even if some associated genes are actually regulated by more than M TFs in the initial network.
In this study, we set the total number of TFs to 80 and the number of target genes to 2,000. The SNR value of gene expression data is 4 dB, and the PFP value of the network is 30 percent. The number of gene expression samples (M) varies from 10 to 100. In this section, we are mainly focused on the problem of TF identification. The AUC performance for sNCA, improved NCA, and LS regression are summarized in Table 5 .
From Table 5 , we can see that the number of gene expression samples has a great impact on the performance for TF identification. When M ¼ 100, which is larger than the TF number 80, both sNCA and NCA work well for the TF activity estimation. Due to the impact of false connections in the network, the AUC value of NCA is 0.952, a little bit lower than that of sNCA, 0.991. When the sample number decreases, the performance of both methods degrades too, but the performance of sNCA is consistently better than NCA. When M ¼ 30, the AUC value for sNCA is 0.921, indicating that a good performance can be achieved by sNCA. This provides us a great confidence about the results that we generate from real data for cancer studies. Even if the sample number is as low as 10, the sNCA approach can provide an AUC performance of 0.851, with an improvement about 0.07 over NCA. Note that sNCA does not have the limitation that the maximum degree for each gene should be lower than the sample number. Therefore, the sampling scheme combined with sNCA can provide a better solution than NCA with an improved AUC performance, possibly for many real applications. Based on information in literature and databases, we have selected about 200 motifs with close relationship to estrogen receptor alpha (ER) signaling, ER pathway, cell cycle and cell death. To construct the initial network, Match [21] is used to search the transcription factor binding sites (TFBS) for their position-weighted matrices (PWMs) that can be extracted from the TRANSFAC 11.1 Professional Database [22] . According to the PWMs provided by the database, a motif score can be calculated for each TF-gene pair. These motif scores provide the initial connection network.
To test the performance of our proposed sNCA approach in real applications, we applied it to two breast cancer patient data sets, Loi data in [23] and MD Anderson (MDA) data in [24] . The breast cancer patient data sets are both consisted of estrogen receptor positive (ERþ) breast patient samples, treated by Tamoxifen. Information gathered from these tumor samples may help us uncover the regulatory mechanism behind the development of antiestrogen drug resistance in breast cancer therapy.
According to patients' survival time recorded in clinical information, for each data set, we divide the patient samples into two groups, "early recurrence" group (survival time smaller than 3 years) and "late recurrence" group (survival time larger than 6 years). The candidate target genes pool is obtained by statistically calculating the p-value for each gene with t-test (threshold p-value 0.05). And furthermore, we categorized them into upregulated (overexpressed in the "late recurrence" group) and downregulated (overexpressed in the "early recurrence" group) gene groups. After mapping to the motif binding data and pruning the network to meet the requirement of FastNCA, the final sample number of gene expression data, gene number, and interested motif number are summarized in Table 6 .
We apply sNCA to each of above four data sets and generate the TFs prioritized by their risk value. Considering that the patient data are quite noisy, different TFs were identified by sNCA for both data sets under similar conditions. The common TFs identified by both data sets are summarized in Table 7 . Through the protein-protein interaction and protein-DNA binding interaction, as shown in Fig. 5 , the identified TFs can be linked together to form a network of TF's regulating gene expression.
To further validate our findings, we tested the above identified TFs on a breast cancer time-series cell line data [25] , where the TF activity is more informative. The gene expression profiles are generated from three separate ER alpha-positive, estrogen dependent breast cancer cell lines grown in the presence of 17beta-estradiol (E2; estrogen). After treatment for intervals varying from 1 to 24 hours, the samples are extracted from the cells (MCF-7, 13 samples; T47D, 14 samples; BT-474, 12 samples). The good quality of the cell line data and preprocessed gene clusters serve as a good base to study the regulatory network related to estrogen dependent breast cancer. We summarize the identified steady TFs in Table 8 .
In Table 8 , it can be seen that most of the TFs generated from patient data in Table 7 also appear in the results of E2-induced cell line study. This makes us more confident to analyze these stable TFs.
ATF2 and ATF3 belong to the ATF/cyclic AMP response element-binding family of TFs. ATF2 can either form homodimers or heterodimers with c-Fos, Fra, or c-Jun, and this dimerization specifically regulates ATF2's ability to either bind to CRE or AP-1 consensus sequences [26] . Although, ATF2 can act as both a tumor suppressor and a tumor promoter, in mammary tumor models, loss of ATF2 transcriptional activity is associated with increased susceptibility to form tumors, and hence, ATF2 may have a tumor suppressive role in breast cancer [27] . While Fig. 5 . Identified common TF network as a result from the two breast cancer patient data sets. "Red" means upregulation in "late recurrence" group, while "green" means downregulation in "late recurrence" group. "Gray" means appearing in both. homodimers of ATF3 are known to be repressors, heterodimers, with Jun or JunB, can activate gene expression [28] .
ELK1 belongs to the ternary complex factor (TCF) subfamily of ETS-domain TFs and can be directly activated by phosphorylation by MAP kinases [29] . ELK1 controls cell migration in several human breast-derived epithelial cell lines, and it may play a role in promoting breast cancer. Furthermore, ELK1 target genes are associated with cell survival and apoptosis in breast epithelial cells.
MYC TF is one of the most deregulated oncoproteins in human cancers, and can contribute to cancer progression through its involvement in several cellular functions including cell cycle progression, proliferation, differentiation, and apoptosis [30] . Activation of MYC is implicated in hormone-independence in vitro and endocrine resistance in breast cancer patients [31] and increased MYC protein levels in tumors are predictive of shorter time to recurrence following adjuvant TAM therapy [32] .
SP1 is overexpressed in various cancers and its expression is often correlated with increased levels of vascular endothelial growth factor (VEGF) expression [33] . In breast cancer cells, SP1 regulates signaling associated with TGF, CCND1, BCL2, E2F1, and purine/pyrimidine synthesis and metabolism [34] . SP1 plays an essential role in mediating hormone-induced cell proliferation in ERþ breast cancer cells.
Although STATs are clearly important for normal mammary gland development, their precise roles in tumorigenesis remain unclear. STAT1 can be phosphorylated by interferon gamma (INFG) and interferon regulatory factor 1 (IRF1). Interestingly, IRF1 expression is decreased in breast cancer cells that are resistant to endocrine therapy [35] . STAT1 may play an inhibitory role in breast tumorigenesis by inhibiting ErbB2/Neu-induced tumor growth [36] . Several types of cancer cells display increased levels of activated STAT3 and STAT5. STAT3 controls cell death in involution in the normal mammary gland, but paradoxically, breast cancer cells express high levels of STAT3 where it can activate proto-oncogenes [37] . Role of STAT5 in breast cancer is more complex and activation of STAT5A/STAT5B can promote tumor growth in earlier stages of breast tumorigenesis; however, in establish breast tumors, these proteins can contribute to mammary epithelial cell differentiation [38] . STAT6 can regulate interleukin-4 (IL4)-mediated decreased cell proliferation and increased apoptosis in breast cancer cells [39] .
For the downstream target genes, we use the procedure as described in Section 2.2 to select the high-ranked target genes for the identified TFs. Totally, we identify about 200 downstream genes, regulated by common TFs of the two data sets. The regulators of these target genes have significant TFA change between the "early recurrence" and "late recurrence" groups. Therefore, they also show significant and consistent pattern associated with their regulators. To a certain extent, these genes have some relationship with the patient survival time. It is reasonable to use these genes as features to cluster the patient samples into "early" or "late" group. Fivefold cross-validation is used to test these genes' prediction performance with a support vector machine (SVM) method [40] .
As shown in Fig. 6 , both ROC curves show good prediction performance of the identified target genes. The AUC value is 0.783 for Loi data and 0.854 for MDA data. If we fix the specificity at 0.7, the sensitivity for Loi data is 0.762 and for MDA data is 0.805. The prediction accuracy is 0.768 for Loi data and 0.855 for MDA data.
We further utilize the ingenuity pathway analyses (IPA) [41] system to perform functional annotations. Among the 200 genes, 92 genes involve in tumorigenesis with p-value 1.73e-8; 61 genes play important roles in proliferation of the cells with p-value 1.56e-6; for the cell death and cell movement, we have 56 and 34 genes, with p-values 7.7e-6 and 3.85e-6, respectively. Especially, there are 27 genes annotated as breast cancer related ones. All of the above-mentioned functions are already known to be involved in the development of cancer. Also, we found some functional networks constructed by the PPI and PDI data. Twenty-five genes form a network, that is, of the function of inflammatory response, cellular movement, immune cell trafficking. Another network with 13 nodes involves in cell-mediated immune response function. We also identified three cancer related networks with node sizes of 15, 13, and 10, respectively. These networks focus on cell-to-cell signaling and interaction; DNA replication, recombination, and repair; and cell death, respectively. For the cellular development, we found two networks with node sizes of 24 and 14. One is focused on the cellular growth and proliferation, while the other is focused on cellular function and maintenance and protein synthesis.
Based on all above analysis, we can see that our identified TFs and downstream target genes are both related to the development and progress of breast cancer. The regulatory network is finally reconstructed by these two layers-TFs and their respective target genes.
CONCLUSION AND DISCUSSION
In this paper, we have proposed a novel approach, sNCA, to prioritize TFs and their target genes. The sNCA approach overcomes a major limitation in many existing methods as caused by the inconsistency between gene expression data and TF-gene binding information. To overcome the limitation of NCA to identify a large number of TFs with limited gene expression samples, we have developed a sampling scheme and combined it with our proposed sNCA for regulatory network identification. Through simulation studies based on multiple factors that affect the network topology or gene expression data, the proposed sNCA approach outperforms both NCA and LS regression, especially when the number of TF is significantly larger than gene expression samples and network topology information has a high level of false connections. The experimental results from two real breast cancer patient data sets have further demonstrated that sNCA can help identify biologically meaningful regulatory networks associated with the development and progression of breast cancer. The identified TFs and their target genes both contribute to the discovery of regulatory mechanism in ERþ breast cancer.
For target gene identification, what we have identified is more based on coregulation and regression. Hence, for each TF, the expression levels of target genes may be quite different. In the future, we would like to jointly use coexpression and coregulation to preprocess gene expression data. In that case, for one thing, we would have more confidence about the estimated TFA pattern, which would be supported by the genes with similar expression pattern; for another, the identified target genes are well supported by both coexpression and coregulation. This could also help facilitate our biologists to design validation experiments for the identified regulatory network.
Although our findings from gene expression data from breast cancer tumors are supported by published research, we have yet to validate the TF-gene interactions in breast cancer models of endocrine resistance in the laboratory. Moreover, the quality of current motif-binding information is not sufficient, and some predicted physical interactions or relationships may not exit at all in a specific cell type. Even though our proposed sNCA is quite robust to the false positives in network, we still need more information to generate a reliable regulatory network. Emerging knowledge from ChIP-on-chip, ChIP-seq, and complex structure [42] studies could provide more reliable TF-binding information. In the future, we plan to generate ChIP-seq data for the TFs that we have identified, to further validate our TF regulatory networks in endocrine resistant breast cancer. Ayesha N. Shajahan received the BS and MS degrees in biological sciences and developmental genetics, respectively, from Wright State University, Dayton, Ohio, and the PhD degree in pharmacology from the University of Illinois in Chicago. She is currently an assistant professor of research in oncology at Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC. Her research interest focus is on understanding mechanisms of drug resistance in cancer.
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